Pennant GroupPNTG +0.99%90 EBITDA Margin % is 6.93% as of Mar. 2026, which is 11% above its 10-year median of 6.24. GuruFocus rates PNTG with a GF Score™ of 90/100 and a GF Value™ of $34.46 (Fairly Valued). The stock has 8 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Pennant Group ranks worse than 61.38% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Pennant Group's EBITDA for the
three
months ended in Mar. 2026 was $20 Mil. Pennant Group's Revenue for the
three
months ended in Mar. 2026 was $285 Mil. Therefore, Pennant Group's EBITDA margin for the quarter that ended in Mar. 2026 was 6.93%.
Pennant Group (NAS:PNTG) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Pennant Group EBITDA Margin % Related Terms
Pennant Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Pennant Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PNTG vs AMN, ARDT, INNV: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Pennant Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pennant Group EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Pennant Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pennant Group (PNTG) has a EBITDA Margin % of 6.93% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Pennant Group and its competitors. This is 11% above median its historical median of 6.24. Over the past decade, Pennant Group's EBITDA Margin % has ranged from 2.15 to 8.25. According to the industry distribution chart, Pennant Group ranks #410 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 61.4%.
Is Pennant Group's EBITDA Margin % too high?
Pennant Group's current EBITDA Margin % of 6.93% is 11% above median its 10-year median of 6.24. Over the past 10 years, this metric has ranged from a low of 2.15 to a high of 8.25. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Pennant Group's value of 6.93% is 32.1% below this industry median. Based on the distribution chart, Pennant Group ranks #410 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pennant Group has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's EBITDA Margin % compare to AMN and ARDT?
According to the Healthcare Providers & Services industry distribution chart, Pennant Group ranks #410 out of 668 companies for EBITDA Margin %. This places Pennant Group in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Pennant Group's value of 6.93% is 32.1% below this benchmark. Historically, Pennant Group's own EBITDA Margin % has ranged from 2.15 to 8.25 over the past decade. While the company's 10-year median is 6.24 vs. the industry median of 10.21, Pennant Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pennant Group's current EBITDA Margin % of 6.93% is 32.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Pennant Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pennant Group's current EBITDA Margin % is 6.93%, which is 11% above median its own 10-year median of 6.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Fairly Valued. The stock's GF Value™ is $34.46, compared to a current price of $34.57 — trading 0.3% above its estimated fair value. The current EBITDA Margin % is 6.93%, which is 11% above median its 10-year median of 6.24 and 32.1% below the Healthcare Providers & Services industry median of 10.21. Pennant Group's overall GF Score™ is 90/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Pennant Group (PNTG), the current EBITDA Margin % is 6.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pennant Group (PNTG) Overvalued in 2026?
Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued.
The current stock price of $34.57 is trading 0.3% above its estimated GF Value™ of $34.46.
GuruFocus considers Pennant Group to be Fairly Valued.
Key valuation signals for PNTG:
EBITDA Margin %: 6.93% (11% above median its 10-year median of 6.24)
GF Value™: $34.46 vs. price of $34.57 (0.3% above fair value)
Industry Position: 32.1% below the Healthcare Providers & Services median (#410 of 668)
No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
90GF Score
Get the complete analysis for PNTG
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNTG has been successfully added to your 
